Company press releases

Viser 1 - 50 av 109 resultater
Tid Selskap Tittel Sektor Kategori
20 Oct 2026
18:00 CEST 		ABL Diagnostics ABL Texcell Diagnostics Announces Termination of Vela Diagnostics Letter of Intent 20103010 Biotechnology Mergers, Acquisitions, Transfers
20 Oct 2026
18:00 CEST 		ABL Diagnostics ABL TEXCELL DIAGNOSTICS ANNONCE LA RÉSILIATION DE LA LETTRE D’INTENTION RELATIVE À VELA DIAGNOSTICS 20103010 Biotechnology Mergers, Acquisitions, Transfers
19 Oct 2026
18:00 CEST 		ABL Diagnostics ABL Texcell Diagnostics Strengthens the Foundations of a Stable Shareholder Base and Pursues Its Growth Strategy 20103010 Biotechnology Other subject
19 Oct 2026
18:00 CEST 		ABL Diagnostics ABL TEXCELL DIAGNOSTICS RENFORCE LES CONDITIONS D’UN ACTIONNARIAT STABLE ET POURSUIT SA STRATÉGIE DE CROISSANCE 20103010 Biotechnology Other subject
16 Oct 2026
17:15 CEST 		ABL Diagnostics ABL TEXCELL DIAGNOSTICS : DÉCLARATION D’APPEL DU MINISTÈRE PUBLIC RELATIVE AU JUGEMENT DE CESSION D’INTEGRAGEN 20103010 Biotechnology Mergers, Acquisitions, Transfers
16 Oct 2026
17:15 CEST 		ABL Diagnostics ABL Texcell Diagnostics: Notice of Appeal by the Public Prosecutor Regarding the IntegraGen Transfer Judgment 20103010 Biotechnology Mergers, Acquisitions, Transfers
12 Oct 2026
08:00 CEST 		ABL Diagnostics ABL Texcell Diagnostics Strengthens Its Presence at Genopole and Opens a New Chapter in Precision Oncology With the Acquisition of IntegraGen’s Assets and Operations 20103010 Biotechnology Mergers, Acquisitions, Transfers
12 Oct 2026
08:00 CEST 		ABL Diagnostics ABL TEXCELL DIAGNOSTICS RENFORCE SON ANCRAGE AU GENOPOLE ET OUVRE UN NOUVEAU CHAPITRE DE DÉVELOPPEMENT EN ONCOLOGIE DE PRÉCISION AVEC LA REPRISE DES ACTIFS ET DES ACTIVITÉS D’INTEGRAGEN 20103010 Biotechnology Mergers, Acquisitions, Transfers
08 Oct 2026
13:00 CEST 		ABL Diagnostics ABL Texcell Diagnostics Announces Availability of All Invest Securities Research Flash Note #8 20103010 Biotechnology Trends / Analyses
08 Oct 2026
13:00 CEST 		ABL Diagnostics ABL TEXCELL DIAGNOSTICS ANNONCE LA PUBLICATION DE LA NOTE FLASH N° 8 ALL INVEST SECURITIES RESEARCH 20103010 Biotechnology Trends / Analyses
01 Oct 2026
18:00 CEST 		ABL Diagnostics ABL TEXCELL DIAGNOSTICS RELÈVE SON OBJECTIF DE CHIFFRE D’AFFAIRES 2026 À UNE FOURCHETTE DE 13,5 M€ À 14,0 M€ 20103010 Biotechnology Sales
01 Oct 2026
18:00 CEST 		ABL Diagnostics ABL Texcell Diagnostics Raises Its 2026 Revenue Guidance to €13.5 Million - €14.0 Million 20103010 Biotechnology Sales
30 Sep 2026
23:30 CEST 		ABL Diagnostics ABL TEXCELL DIAGNOSTICS : MISE À DISPOSITION DU RAPPORT SEMESTRIEL 2026 20103010 Biotechnology Legal
30 Sep 2026
23:30 CEST 		ABL Diagnostics ABL Texcell Diagnostics: Availability of the 2026 Half-Year Financial Report 20103010 Biotechnology Legal
21 Sep 2026
19:00 CEST 		ABL Diagnostics ABL Texcell Diagnostics franchit une nouvelle étape stratégique avec un projet d’acquisition des activités de Vela Diagnostics à Singapour et aux États-Unis 20103010 Biotechnology Alliances and agreements
21 Sep 2026
19:00 CEST 		ABL Diagnostics ABL Texcell Diagnostics Reaches a New Strategic Milestone With a Proposed Acquisition of Vela Diagnostics' Activities in Singapore and the United States 20103010 Biotechnology Alliances and agreements
18 Sep 2026
20:00 CEST 		ABL Diagnostics ABL TEXCELL DIAGNOSTICS :MODIFICATION DES RESSOURCES ALLOUEES AU CONTRAT DE LIQUIDITE 20103010 Biotechnology Legal
17 Sep 2026
20:00 CEST 		ABL Diagnostics ABL Diagnostics Becomes ABL Texcell Diagnostics 20103010 Biotechnology Legal
17 Sep 2026
20:00 CEST 		ABL Diagnostics ABL DIAGNOSTICS DEVIENT ABL TEXCELL DIAGNOSTICS 20103010 Biotechnology Legal
17 Sep 2026
18:00 CEST 		ABL Diagnostics ABL Diagnostics Announces Its Participation in Investor Access @ Maison De La Chimie Paris 2026 20103010 Biotechnology Other subject
17 Sep 2026
18:00 CEST 		ABL Diagnostics ABL DIAGNOSTICS ANNONCE SA PARTICIPATION À INVESTOR ACCESS @ MAISON DE LA CHIMIE PARIS 2026 20103010 Biotechnology Other subject
15 Sep 2026
18:00 CEST 		ABL Diagnostics ABL Diagnostics to Participate in the European Main MidCap Event Paris 2026 on September 30 and October 1, 2026 20103010 Biotechnology Other subject
15 Sep 2026
18:00 CEST 		ABL Diagnostics ABL DIAGNOSTICS PARTICIPERA AU EUROPEAN MAIN MIDCAP EVENT PARIS 2026 LES 30 SEPTEMBRE ET 1er OCTOBRE 2026 20103010 Biotechnology Other subject
14 Sep 2026
20:00 CEST 		ABL Diagnostics ABL Diagnostics Announces Availability of the Latest All Invest Securities Research Report 20103010 Biotechnology Rating
14 Sep 2026
20:00 CEST 		ABL Diagnostics ABL Diagnostics annonce la mise à disposition du dernier rapport d'analyse d'All Invest Securities 20103010 Biotechnology Rating
11 Sep 2026
12:01 CEST 		ABL Diagnostics ABL Diagnostics (ABLD) Announces the Filing of a Takeover Bid for Integragen 20103010 Biotechnology Mergers, Acquisitions, Transfers
11 Sep 2026
12:01 CEST 		ABL Diagnostics ABL Diagnostics (ABLD) annonce le dépôt d’une offre de reprise de IntegraGen 20103010 Biotechnology Mergers, Acquisitions, Transfers
10 Sep 2026
18:00 CEST 		ABL Diagnostics ABL Diagnostics - TEXCELL Strengthens Its Position as an International Reference in Safety and Viral Clearance With a New Strategic Partnership With ABIONYX Pharma 20103010 Biotechnology Alliances and agreements
10 Sep 2026
18:00 CEST 		ABL Diagnostics ABL DIAGNOSTICS - TEXCELL RENFORCE SA POSITION DE RÉFÉRENCE INTERNATIONALE EN SÉCURITÉ ET CLAIRANCE VIRALE AVEC UN NOUVEAU PARTENARIAT STRATÉGIQUE AVEC ABIONYX PHARMA 20103010 Biotechnology Alliances and agreements
08 Sep 2026
18:28 CEST 		ABL Diagnostics ABL DIAGNOSTICS CONFIRME SON CHANGEMENT D’ÉCHELLE AU PREMIER SEMESTRE 2026 : CHIFFRE D’AFFAIRES EN CROISSANCE DE 90,0 %, EBITDA MULTIPLIÉ PAR PLUS DE QUATRE ET RÉSULTAT NET EN HAUSSE DE 343,3 % PAR RAPPORT AU PREMIER SEMESTRE 2025 20103010 Biotechnology Income
08 Sep 2026
18:28 CEST 		ABL Diagnostics ABL Diagnostics Confirms Its Change of Scale in the First Half of 2026: Revenue up 90.0%, EBITDA Multiplied by More Than Four and Net Income up 343.3% Compared to the First Half of 2025 20103010 Biotechnology Income
27 Aug 2026
18:00 CEST 		ABL Diagnostics ABL Diagnostics: Information Relating to the Total Number of Voting Rights and the Number of Shares Constituting the Share Capital 20103010 Biotechnology General meeting / Board Meeting
27 Aug 2026
18:00 CEST 		ABL Diagnostics ABL Diagnostics: INFORMATIONS RELATIVES AU NOMBRE TOTAL DE DROITS DE VOTE ET AU NOMBRE D’ACTIONS COMPOSANT LE CAPITAL SOCIAL 20103010 Biotechnology General meeting / Board Meeting
27 Aug 2026
18:00 CEST 		ABL Diagnostics ABL Diagnostics: Ordinary and Extraordinary General Meeting of September 17, 2026 – Arrangements for the Availability and Consultation of Preparatory Documents 20103010 Biotechnology General meeting / Board Meeting
27 Aug 2026
18:00 CEST 		ABL Diagnostics ABL Diagnostics : ASSEMBLÉE GÉNÉRALE ORDINAIRE ET EXTRAORDINAIRE DU 17 SEPTEMBRE 2026 – MODALITÉS DE MISE À DISPOSITION OU DE CONSULTATION DES DOCUMENTS PRÉPARATOIRES 20103010 Biotechnology General meeting / Board Meeting
07 Aug 2026
18:00 CEST 		ABL Diagnostics ABL Diagnostics - Projet de transfert de la cotation de ses titres du marché réglementé d'Euronext Paris vers Euronext Growth Paris 20103010 Biotechnology General meeting / Board Meeting
07 Aug 2026
18:00 CEST 		ABL Diagnostics ABL Diagnostics - Proposed Transfer of the Listing of Its Securities From the Regulated Market of Euronext Paris to Euronext Growth Paris 20103010 Biotechnology General meeting / Board Meeting
29 Jul 2026
18:00 CEST 		ABL Diagnostics ABL Diagnostics: Sale of a New Block of Shares by Its Main Shareholder ABL 20103010 Biotechnology Other subject
29 Jul 2026
18:00 CEST 		ABL Diagnostics ABL Diagnostics : Cession d'un nouveau bloc d'actions par son actionnaire principal ABL 20103010 Biotechnology Other subject
27 Jul 2026
18:00 CEST 		ABL Diagnostics ABL Diagnostics Announces Amendment to the Equity Line and Share Loan Agreement Between Its Main Shareholder ABL SA (Luxembourg) and Alumni Capital 20103010 Biotechnology Other subject
27 Jul 2026
18:00 CEST 		ABL Diagnostics ABL Diagnostics annonce la signature d'un avenant au contrat d'Equity Line et de prêt de titres entre son actionnaire principal ABL SA (Luxembourg) et Alumni Capital 20103010 Biotechnology Other subject
23 Jul 2026
09:22 CEST 		ABL Diagnostics ABL Diagnostics désignée par le Tribunal de commerce d'Évry pour la reprise des activités de TEXCELL 20103010 Biotechnology Other financial transaction
23 Jul 2026
09:22 CEST 		ABL Diagnostics ABL Diagnostics Selected by the Évry Commercial Court to Acquire TEXCELL’s Operations 20103010 Biotechnology Other financial transaction
22 Jul 2026
18:00 CEST 		ABL Diagnostics ABL Diagnostics: Sale of a New Block of Shares by Its Main Shareholder ABL 20103010 Biotechnology Other financial transaction
22 Jul 2026
18:00 CEST 		ABL Diagnostics ABL Diagnostics : Cession d'un nouveau bloc d'actions par son actionnaire principal ABL 20103010 Biotechnology Other financial transaction
15 Jul 2026
08:00 CEST 		ABL Diagnostics ABL Diagnostics Informed that its Reference Shareholder ABL Has Crossed Below the 95% Threshold 20103010 Biotechnology Legal
15 Jul 2026
08:00 CEST 		ABL Diagnostics ABL Diagnostics informée du franchissement à la baisse du seuil de 95 % par son actionnaire de référence ABL 20103010 Biotechnology Legal
13 Jul 2026
08:00 CEST 		ABL Diagnostics ABL DIAGNOSTICS : BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITÉ S1 2026 20103010 Biotechnology Legal
10 Jul 2026
08:00 CEST 		ABL Diagnostics ABL Diagnostics: Sale of a New Block of Shares by Its Main Shareholder ABL 20103010 Biotechnology Share history
10 Jul 2026
08:00 CEST 		ABL Diagnostics ABL Diagnostics : Cession d'un nouveau bloc d'actions par son actionnaire principal ABL 20103010 Biotechnology Share history